SINGAPORE, May 24, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex's AI-based stain-free digital pathology platform has long been established as a suitable tool for global clinical guidelines that outline the assessment, prevention and treatment of Chronic Hepatitis B (CHB)...
from PR Newswire: https://ift.tt/36u6nn9
No comments:
Post a Comment